COAG
Hemab Therapeutics Holdings, Inc.
33.10$
-4.7%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Hemab Therapeutics Holdings, Inc. (COAG) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -61 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2024 | 2025 |
|---|---|---|
| -46 | -61 | |
| 0.2 | 0.3 | |
| 1.9 | 2.0 | |
| 1.4 | 1.4 | |
| 0.3 | 0.0 | |
| – | -81 | |
| -0.1 | -0.1 | |
| -0.1 | 156 | |
| 16 | 14 | |
| -46 | -61 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.